![Gina Chapman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 30/06/2026
Gina Chapman currently works at Entrada Therapeutics, Inc., as Independent Director from 2023 and Verizon Capital Corp., as Manager.
Ms. Chapman also formerly worked at Cargo Therapeutics, Inc., as President, Chief Executive Officer & Director from 2022 to 2025 and Roche Group, as Senior Vice President-Business Unit Head from 2021 to 2022.
Ms. Chapman received her undergraduate degree from the University of California, Santa Barbara.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/09/2023 |
Verizon Capital Corp.
 Verizon Capital Corp. Finance/Rental/LeasingFinance Provides equipment rental and lease financing | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| CARO THERPAR | Amministratore Delegato | 18/03/2025 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | 01/04/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Verizon Capital Corp.
Verizon Capital Corp. Finance/Rental/LeasingFinance Provides equipment rental and lease financing | Finance |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
Cargo Therapeutics, Inc.
 Cargo Therapeutics, Inc. BiotechnologyHealth Technology Engages in generation of adoptive cell therapies for cancer treatment | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
